Abstract
Aim
To summarize the major findings of the five Cochrane reviews on substitution maintenance treatments for opioid dependence.Methods
We conducted a narrative and quantitative summary of systematic review findings. There were 52 studies included in the original reviews (12,075 participants, range 577-5894): methadone maintenance treatment (MMT) was compared with methadone detoxification treatment (MDT), no treatment, different dosages of MMT, buprenorphine maintenance treatment (BMT), heroin maintenance treatment (HMT), and l-alpha-acetylmethadol (LAAM) maintenance treatment (LMT).Measurements
Outcomes considered were retention in treatment, use of heroin and other drugs during treatment, mortality, criminal activity, and quality of life.Findings
Retention in treatment: MMT is more effective than MDT, no treatment, BMT, LMT, and heroin plus methadone. MMT proved to be less effective than injected heroin alone. High doses of methadone are more effective than medium and low doses. Use of heroin: MMT is more effective than waiting list, less effective than LAAM, and not different from injected heroin. No significant results were available for mortality and criminal activity.Conclusions
These findings confirm that MMT at appropriate doses is the most effective in retaining patients in treatment and suppressing heroin use but show weak evidence of effectiveness toward other relevant outcomes. Future clinical trials should collect data on a broad range of health outcomes and recruit participants from heterogeneous practice settings and social contexts to increase generalizability of results.Citations & impact
Impact metrics
Article citations
Persistence in the Methadone Maintenance Program and Its Relationship with the Medication Regimen Complexity Index in Opioid-Dependent Patients.
Pharmaceuticals (Basel), 17(5):567, 29 Apr 2024
Cited by: 0 articles | PMID: 38794137 | PMCID: PMC11123973
Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway.
Addict Sci Clin Pract, 19(1):37, 14 May 2024
Cited by: 0 articles | PMID: 38741162 | PMCID: PMC11092244
County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities.
PLoS One, 19(4):e0301863, 05 Apr 2024
Cited by: 0 articles | PMID: 38578818 | PMCID: PMC10997118
Canadian Addiction Treatment Centre (CATC) opioid agonist treatment cohort in Ontario, Canada.
BMJ Open, 14(2):e080790, 24 Feb 2024
Cited by: 0 articles | PMID: 38401902 | PMCID: PMC10895228
Insufficient Impact: Limited Implementation of Federal Regulatory Changes to Methadone and Buprenorphine Access in Arizona During COVID-19.
AJPM Focus, 3(2):100177, 24 Dec 2023
Cited by: 0 articles | PMID: 38312524 | PMCID: PMC10835120
Go to all (285) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Health Technol Assess, 11(9):1-171, iii-iv, 01 Jan 2007
Cited by: 238 articles | PMID: 17313907
ReviewBooks & documents Free full text in Europe PMC
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Cochrane Database Syst Rev, (2):CD002207, 06 Feb 2014
Cited by: 456 articles | PMID: 24500948 | PMCID: PMC10617756
Review Free full text in Europe PMC
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Cochrane Database Syst Rev, (4):CD002207, 01 Jan 2002
Cited by: 11 articles | PMID: 12519569
Review
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Cochrane Database Syst Rev, (3):CD002207, 01 Jan 2004
Cited by: 168 articles | PMID: 15266465
Review